46 - Pharmacology Perspectives on Attaining Diversity, Equity and Inclusion in Clinical Trials

Session Chair(s)

• Pamela Hornby

  Janssen

• Deborah Luessen

  Speaker
  Vanderbilt University

This symposium aims to increase awareness of the ongoing and pervasive issues surrounding inequality in clinical trial development and provide insights on how these factors impact the validity and use of clinical trial results that currently perpetuate health disparities. This symposium will highlight the pharmacological insights and novel strategies to diversify scientific approaches involved in pharmacotherapeutic clinical trial design, execution and outcome analysis to overcome barriers for patients from underrepresented populations. The symposium will provide unique perspectives from leaders in the field of pharmacology representing a broad range of disciplines (industry, academia, government). The speakers have been selected based on their alignment with pharmacological scientific approaches and will present on topics of interest to a broad group of preclinical and clinical pharmacologists.

Presentations:

• 1:30 PM – 1:33 PM

  Introduction
  

  Speaker: Deborah Luessen – Vanderbilt University
• 1:33 PM – 1:53 PM

  J&J Diversity and Inclusion in Clinical Trials with Highlights from ENSEMBLE (COVID-19 Vaccine)
  

  Speaker: Jorge Hechavarria – Janssen
• 1:53 PM – 2:13 PM

  Ensuring that Patients of Color have Access to Clinical Trials: Diversity in Drug Discovery Genomic Databanks
  

  Speaker: Sapna McManus – Genentech
• 2:13 PM – 2:33 PM

  FDA Efforts to Advance Racial and Ethnic Minority Participation in Clinicals Trials
  

  Speaker: Richardae Araojo – CDER/FDA
• 2:33 PM – 2:58 PM

  Round-table Q&A Session
• 2:58 PM – 3:00 PM

  Conclusion